DashboardAll companies
Run this on your own research
Healthcare · Diagnostics & Research

Waters Corporation

WATNYSE$453.67−$1.92 (−0.42%)Market closed

Price Chart

Daily

Key facts

Market Cap
$44.55B
P/E
42.0x
P/B
10.54x
ROE
29.3%

Waters Corporation

Healthcare · Diagnostics & Research · FY 2025

Waters Corporation is a leading entity in the field of analytical instruments and software. It primarily focuses on providing laboratory solutions for a variety of sectors, including pharmaceuticals, healthcare, food and beverage, and chemical analysis. The company's offerings include high-performance liquid chromatography, mass spectrometry systems, and various supporting technologies used for advanced research in life sciences. Waters Corporation is pivotal in enhancing laboratory productivity, offering cutting-edge research tools that assist in drug development, quality control, and environmental testing. Operating globally, it serves a wide array of clients, including academic institutions, government agencies, and private industry players. With its commitment to innovation and precision, Waters Corporation plays a crucial role in advancing scientific and technological progress in multiple critical industries worldwide.

CEO
Dr. Udit Batra Ph.D.
Employees
7,600
Website
waters.com

Company Statistics

Valuation

P/E
42.0x
P/B
10.54x
P/S
8.53x
EV/EBITDA
26.1x
P/FCF
50.0x

Margins

Gross
59.3%
EBITDA
32.6%
Operating
25.4%
Pre-Tax
23.8%
Net
20.3%

Returns

ROA
13.3%
ROE
29.3%
ROIC
17.1%

Growth (CAGR)

Rev 3Yr
2.1%
Rev 5Yr
6.0%
Op Inc 3Yr
−3.1%
Net Inc 3Yr
−3.2%

Financial Health

Cash & Cash Equivalents
$587.8M
Net Debt
$1.93B
Debt/Equity
98.2%
Interest Cov
—

Profile

Revenue
$3.17B
Shares Out
—
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
Waters Corporation (WAT) Stock Forecast 2026 $453.67 — Price, Financials & Analyst Targets | AlphaLenz